Feed Preview

Fast Growing

Genome Editing & T-Cells

Genome Editing & T-Cells diagram by Rahman et al, PLOS Genetics
Rahman et al, PLOS Genetics

Genome editing technologies enable the editing of genes to create or correct mutations or express genes of interest. Here is the latest research on genome editing in T- cells and their application in human diseases such as adoptive T-cell immunotherapy for cancer.

Top 20 most recent papers
Cancer Treatment and Research

CAR T Cell Therapy Progress and Challenges for Solid Tumors

Cancer Treatment and ResearchMarch 28, 2020
Lawrence A SternSaul J Priceman
1
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases

Alternatives to antibiotics in a One Health context and the role genomics can play in reducing antimicrobial use

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious DiseasesMarch 30, 2020
Jolinda PollockDavid L Gally
12
European Journal of Human Genetics : EJHG

Gene therapy regulation: could in-body editing fall through the net?

European Journal of Human Genetics : EJHGMarch 28, 2020
Miranda Mourby, Michael Morrison
4
Frontiers in Immunology

A20 Restricts Inflammatory Response and Desensitizes Gingival Keratinocytes to Apoptosis

Frontiers in ImmunologyMarch 29, 2020
Yajie LiSinem Esra Sahingur
Trends in Cancer

Identification of Antigenic Targets

Trends in CancerMarch 27, 2020
Hans-Peter GerberMarvin H Gee
3
Frontiers in Immunology

Progress and Challenges in Precise Treatment of Tumors With PD-1/PD-L1 Blockade

Frontiers in ImmunologyApril 1, 2020
Youhai JiangHongyang Wang
1
Methods in Molecular Biology

Application of CRISPR/Cas9-Mediated Genome Editing in Leishmania

Methods in Molecular BiologyMarch 30, 2020
Wen-Wei ZhangGreg Matlashewski
1
Molecular Therapy : the Journal of the American Society of Gene Therapy

CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens

Molecular Therapy : the Journal of the American Society of Gene TherapyMarch 26, 2020
Neal D ShoreJeffrey M Skolnik
4
Molecular Plant

Plant prime editors enable precise gene editing in rice cells

Molecular PlantMarch 31, 2020
Xu TangYong Zhang
The Journal of Physical Chemistry. B

CRISPR-CaS9 Genome Interrogation: A Facilitated Sub-Diffusive Target Search Strategy

The Journal of Physical Chemistry. BMarch 28, 2020
Diljith Thonnekottu, Debarati Chatterjee
Journal of Community Genetics

Gene editing and disabled people: a response to Felicity Boardman

Journal of Community GeneticsMarch 30, 2020
Iñigo de Miguel Beriain
3
Journal of the Chinese Medical Association : JCMA

The update of chimeric antigen receptor (CAR) -T cells therapy in Glioblastoma

Journal of the Chinese Medical Association : JCMAMarch 29, 2020
Chi-Jen ChouYi-Yen Lee
Yi chuan = Hereditas

Next-generation CRISPR-Cas for genome editing: focusing on the Cas protein and PAM

Yi chuan = HereditasMarch 29, 2020
Lian Chao Tang, Feng Gu
3
Frontiers in Plant Science

Biosafety Regulatory Reviews and Leeway to Operate: Case Studies From Sub-Sahara Africa

Frontiers in Plant ScienceMarch 27, 2020
John KomenDoris Wangari
Folia Histochemica Et Cytobiologica

Monocytic MDSC as a source of immunosuppressive cytokines in chronic lymphocytic leukemia (CLL) microenvironment

Folia Histochemica Et CytobiologicaApril 1, 2020
Wioleta Kowalska, Agnieszka Bojarska-Junak
1

See more papers from this feed

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing is used to reveal the presence and quantity of RNA in a given sample. In this feed, RNA sequencing investigates the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA sequencing and this disease.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

© 2020 Meta ULC. All rights reserved
/feed-previews/genome-editing-t-cells/bd00f2ee-9174-47d6-911b-1058f33fcf8e